To characterize the molecular landscape of EGFR-mutant NSCLC, we used 5 patient databases with genomic profiling (Methods), representing 16,715 patients with EGFR-mutant NSCLC. This evidence concerns the gene EGFR and non-small cell lung carcinoma.